• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SYNTAX 评分在预测无保护左主干冠状动脉疾病经皮冠状动脉介入治疗后临床转归中的作用。

Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.

机构信息

Dipartimento di Cardiologia, Ospedale Ferrarotto, Università di Catania, Italy.

出版信息

Circ Cardiovasc Interv. 2009 Aug;2(4):302-8. doi: 10.1161/CIRCINTERVENTIONS.108.847137. Epub 2009 Jun 30.

DOI:10.1161/CIRCINTERVENTIONS.108.847137
PMID:20031732
Abstract

BACKGROUND

The SYNTAX score (SXscore) has been proposed recently as a valuable tool to characterize the coronary vasculature prospectively with respect to the number of lesions and their functional impact, location, and complexity. However, the prognostic value of SXscores in patients undergoing percutaneous coronary intervention of the left main artery has not been validated.

METHODS AND RESULTS

We applied the SXscore in 255 consecutive patients who underwent percutaneous coronary intervention for left main disease and explored its performance with respect to their clinical outcome. Univariate and multivariate Cox proportional hazard regression analyses were performed to evaluate the relation between the SXscore and the incidence of cardiac mortality, the primary end point of the study, and major adverse cardiac events (MACE). At 1 year, the SXscore significantly predicted the risk of cardiac death (hazard ratio, 1.12/unit increase; 95% CI, 1.06 to 1.18; P<0.001) and MACE (hazard ratio, 1.59/unit increase; 95% CI, 1.02 to 2.48; P=0.043). After adjustment for potential confounders, a higher SXscore remained significantly associated with cardiac mortality (adjusted hazard ratio, 1.15; 95% CI, 1.05 to 1.26; P=0.003) and MACE (adjusted hazard ratio, 1.06; 95% CI, 1.02 to 1.10; P=0.005). C-indexes for SXscores in terms of cardiac death and MACE were 0.83 and 0.64, respectively. Using classification tree analysis, discrimination levels of 34 and 37 were identified as the optimal cutoff to distinguish between patients at low and high risk of cardiac death and MACE, respectively.

CONCLUSIONS

The SXscore is a useful tool to predict cardiac mortality and MACE in patients undergoing percutaneous revascularization of the left main coronary artery.

摘要

背景

最近提出了 SYNTAX 评分(SXscore),作为一种有价值的工具,可以前瞻性地描述冠状动脉病变的数量及其功能影响、位置和复杂性。然而,SXscore 在接受经皮冠状动脉介入治疗左主干病变的患者中的预后价值尚未得到验证。

方法和结果

我们在 255 例连续接受经皮冠状动脉介入治疗左主干疾病的患者中应用了 SXscore,并探讨了其与临床结局的关系。进行单变量和多变量 Cox 比例风险回归分析,以评估 SXscore 与心脏死亡率(研究的主要终点)和主要不良心脏事件(MACE)发生率之间的关系。在 1 年时,SXscore 显著预测了心脏死亡的风险(风险比,每增加 1 个单位增加 1.12;95%CI,1.06 至 1.18;P<0.001)和 MACE(风险比,每增加 1 个单位增加 1.59;95%CI,1.02 至 2.48;P=0.043)。在校正潜在混杂因素后,较高的 SXscore 仍与心脏死亡率(校正风险比,1.15;95%CI,1.05 至 1.26;P=0.003)和 MACE(校正风险比,1.06;95%CI,1.02 至 1.10;P=0.005)显著相关。SXscore 在心脏死亡和 MACE 方面的 C 指数分别为 0.83 和 0.64。使用分类树分析,确定 34 和 37 作为区分低危和高危心脏死亡和 MACE 患者的最佳截断值。

结论

SXscore 是预测接受经皮左主干冠状动脉血运重建的患者心脏死亡和 MACE 的有用工具。

相似文献

1
Usefulness of the SYNTAX score for predicting clinical outcome after percutaneous coronary intervention of unprotected left main coronary artery disease.SYNTAX 评分在预测无保护左主干冠状动脉疾病经皮冠状动脉介入治疗后临床转归中的作用。
Circ Cardiovasc Interv. 2009 Aug;2(4):302-8. doi: 10.1161/CIRCINTERVENTIONS.108.847137. Epub 2009 Jun 30.
2
Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.对比 NERS(新风险分层)评分和 SYNTAX(经皮冠状动脉介入治疗与心脏手术联合治疗)评分在非保护左主干支架置入术预后预测中的价值。
JACC Cardiovasc Interv. 2010 Jun;3(6):632-41. doi: 10.1016/j.jcin.2010.04.006.
3
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial.SYNTAX 评分对依维莫司和佐他莫司洗脱支架血运重建后 1 年结局的预后价值:RESOLUTE 所有患者试验的一项亚组研究。
JACC Cardiovasc Interv. 2011 Apr;4(4):432-41. doi: 10.1016/j.jcin.2011.01.008.
4
The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.基于解剖和临床的 NERS(新风险分层)评分 II 预测无保护左主干冠状动脉疾病支架置入后的临床结局:来自多中心、前瞻性登记研究的结果。
JACC Cardiovasc Interv. 2013 Dec;6(12):1233-41. doi: 10.1016/j.jcin.2013.08.006. Epub 2013 Nov 13.
5
A patient-level pooled analysis assessing the impact of the SYNTAX (synergy between percutaneous coronary intervention with taxus and cardiac surgery) score on 1-year clinical outcomes in 6,508 patients enrolled in contemporary coronary stent trials.一项患者水平的汇总分析评估了 SYNTAX(紫杉醇经皮冠状动脉介入治疗与心脏手术联合)评分对 6508 例当代冠状动脉支架试验患者 1 年临床结局的影响。
JACC Cardiovasc Interv. 2011 Jun;4(6):645-53. doi: 10.1016/j.jcin.2011.02.018.
6
Predictive value of SYNTAX score in risk stratification of patients undergoing unprotected left main coronary artery angioplasty.SYNTAX评分在无保护左主干冠状动脉血管成形术患者风险分层中的预测价值。
J Invasive Cardiol. 2011 Dec;23(12):494-9.
7
Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.在接受经皮或外科左主干血运重建的患者中,全球风险分类和临床 SYNTAX(经皮冠状动脉介入治疗与紫杉醇和心脏手术之间的协同作用)评分。
JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.
8
Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.心肌梗死患者使用药物洗脱支架行无保护左主干冠状动脉经皮冠状动脉介入治疗的多中心国际注册研究
Catheter Cardiovasc Interv. 2009 Jan 1;73(1):15-21. doi: 10.1002/ccd.21712.
9
Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.SYNTAX评分在选择接受冠状动脉旁路移植术治疗的左主干冠状动脉疾病患者中的应用价值。
JACC Cardiovasc Interv. 2009 Aug;2(8):731-8. doi: 10.1016/j.jcin.2009.06.003.
10
First generation versus new generation drug-eluting stents for the treatment of ostial/midshaft lesions in unprotected left main coronary artery: the Milan and New-Tokyo (MITO) registry.第一代与新一代药物洗脱支架治疗无保护左主干冠状动脉开口/中段病变:米兰和新东京(MITO)注册研究。
Catheter Cardiovasc Interv. 2015 Feb 15;85(3):E63-9. doi: 10.1002/ccd.25624. Epub 2014 Aug 20.

引用本文的文献

1
Assessment of acute coronary syndromes among patients with left main coronary artery disease in centers with and without cardiac surgery on-site. Data from PL-ACS registry.在有和没有现场心脏手术的中心评估左主干冠状动脉疾病患者的急性冠状动脉综合征。来自波兰急性冠状动脉综合征(PL-ACS)注册研究的数据。
Cardiol J. 2025;32(3):278-290. doi: 10.5603/cj.98087. Epub 2025 May 21.
2
The current state of the multidisciplinary heart team approach: a systematic review.多学科心脏团队方法的现状:一项系统综述。
Eur J Cardiothorac Surg. 2024 Dec 26;67(1). doi: 10.1093/ejcts/ezae461.
3
Residual coronary artery tree description and lesion EvaluaTion (CatLet) score, clinical variables, and their associations with outcome predictions in patients with acute myocardial infarction.
急性心肌梗死患者的残余冠状动脉树描述和病变评估(CatLet)评分、临床变量及其与预后预测的关系。
Chin Med J (Engl). 2023 Oct 20;136(20):2459-2467. doi: 10.1097/CM9.0000000000002640. Epub 2023 Apr 12.
4
The performance of SYNTAX score versus the coronary angiogram standard evaluation in the prediction of cardiovascular events in a cohort of patients with stable coronary heart disease.在一组稳定型冠心病患者中,SYNTAX评分与冠状动脉造影标准评估在预测心血管事件方面的表现。
Cardiovasc Diagn Ther. 2022 Oct;12(5):563-576. doi: 10.21037/cdt-22-172.
5
Impact of Metabolic Syndrome and Its Components on Clinical Severity and Long-Term Prognosis in Patients With Premature Myocardial Infarction.代谢综合征及其组分对早发性心肌梗死患者临床严重程度和长期预后的影响。
Front Endocrinol (Lausanne). 2022 Jun 30;13:920470. doi: 10.3389/fendo.2022.920470. eCollection 2022.
6
Prognostic value of CHA2DS2-VASc score in predicting high SYNTAX score and in-hospital mortality for non-ST elevation myocardial infarction in patients without atrial fibrillation.CHA2DS2-VASc 评分对非心房颤动的非 ST 段抬高型心肌梗死患者高 SYNTAX 评分和住院死亡率的预测价值。
Anatol J Cardiol. 2021 Nov;25(11):789-795. doi: 10.5152/AnatolJCardiol.2021.03982.
7
Association Between Morning Surge in Systolic Blood Pressure and SYNTAX Score I in Patients With Stable Coronary Artery Disease.稳定型冠状动脉疾病患者清晨收缩压波动与 SYNTAX 评分 I 的关系。
Tex Heart Inst J. 2021 Jun 4;48(2). doi: 10.14503/THIJ-19-7092.
8
Pcsk9 is associated with severity of coronary artery lesions in male patients with premature myocardial infarction.载脂蛋白 C-3 酶与男性早发性心肌梗死患者冠状动脉病变严重程度相关。
Lipids Health Dis. 2021 May 27;20(1):56. doi: 10.1186/s12944-021-01478-w.
9
Dyslipidemia, Not Inflammatory Markers or Adipokines, Contributes Significantly to a Higher SYNTAX Score in Stable Coronary Artery Disease (from the Taichung CAD Study).血脂异常而非炎症标志物或脂肪因子,对稳定型冠状动脉疾病患者较高的SYNTAX评分有显著影响(来自台中冠心病研究)。
Acta Cardiol Sin. 2021 May;37(3):232-238. doi: 10.6515/ACS.202105_37(3).20201116B.
10
Fallacies and Possible Remedies of the SYNTAX Score.SYNTAX 评分的谬误与可能的补救措施。
J Interv Cardiol. 2020 Dec 15;2020:8822308. doi: 10.1155/2020/8822308. eCollection 2020.